4/10
10:19 am
ACAD
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
4/10
09:32 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
4/9
08:09 am
ACAD
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $32.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $32.00 price target on the stock.
4/9
06:27 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
4/9
06:27 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/25
09:19 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/13
12:01 pm
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/13
12:01 pm
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
02:02 pm
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
02:02 pm
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
10:39 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
10:39 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
09:23 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
08:12 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
08:12 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
07:58 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
07:58 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
07:08 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
06:46 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
06:46 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
06:14 am
ACAD
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was downgraded by analysts at Mizuho to a "neutral" rating. They now have a $25.00 price target on the stock, down previously from $39.00.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was downgraded by analysts at Mizuho to a "neutral" rating. They now have a $25.00 price target on the stock, down previously from $39.00.
3/12
06:14 am
ACAD
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was downgraded by analysts at Mizuho to a "neutral" rating. They now have a $25.00 price target on the stock, down previously from $39.00.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was downgraded by analysts at Mizuho to a "neutral" rating. They now have a $25.00 price target on the stock, down previously from $39.00.
3/12
05:55 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
05:55 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD
3/12
05:25 am
ACAD
Rating for ACAD
Low
Report
Rating for ACAD